Shanghai, China

Jin Zhong

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Chinese Academy of Sciences, Shanghai Institute of Pharmaceutical Industry. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jin Zhong. Retrieved from https://idiyas.com/inventor/jin-zhong-v9iitexr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jin Zhong - Innovator in Anti-HCV Medicaments

Introduction

Jin Zhong is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-HCV medicaments. His innovative approach combines traditional Chinese medicine with modern scientific techniques.

Latest Patents

Jin Zhong holds a patent for the use of 9,10-anthraquinone compounds. This patent discloses the application of these compounds or their pharmaceutical salts in the preparation of anti-HCV medicaments. The compounds are recognized for being cost-effective, safe, and effective, primarily derived from traditional Chinese medicines. They exhibit better anti-HCV effects with lighter side effects compared to existing treatments.

Career Highlights

Throughout his career, Jin Zhong has worked with esteemed institutions such as the Shanghai Institute of Pharmaceutical Industry and the Chinese Academy of Sciences. His work has been pivotal in advancing the understanding and treatment of HCV infections.

Collaborations

Jin Zhong has collaborated with notable colleagues, including Wen Gao and Changlong Zhuang. Their combined expertise has contributed to the success of his research and innovations.

Conclusion

Jin Zhong's contributions to the field of anti-HCV medicaments highlight the importance of integrating traditional medicine with modern science. His innovative work continues to pave the way for effective treatments in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…